Home
NICE Guidance
Conditions and diseases
Cancer
Renal cancer

Nivolumab with ipilimumab for untreated advanced renal cell carcinoma

Technology appraisal guidance [TA581] Published: 15 May 2019

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 780.